OSIRISKapitalSign in

Company profile · free preview

AbCellera Biologics Inc.

ABCL · NASDAQ · Healthcare · Updated 10/25/2026

Revenue

$75.1M

Fiscal 2025

Net income

(146.4M)

Fiscal 2025

Free cash flow

(174.1M)

Fiscal 2025

Net cash / (debt)

—

Fiscal 2025

Five-year financials

Fiscal year20252024202320222021
Revenue$75.1M$28.8M$38.0M$485.4M$375.2M
Net income(146.4M)(162.9M)(146.4M)$158.5M$153.5M
Diluted EPS—————
Operating cash flow(131.3M)(108.6M)(43.9M)$277.4M$244.6M
Free cash flow(174.1M)(187.0M)(120.8M)$206.7M$186.1M
Cash$128.5M$156.3M$133.3M$386.5M$476.1M
Total debt—————

Where the cash went

Cumulative, fiscal 2021–2025, straight from the reported cash-flow statements.

Reinvested in capex

137.4%

of operating cash flow

Returned to owners

—

of free cash flow (buybacks + dividends)

Diluted share count

—

change 2021–2025

Capital expenditure $327.2MBar width = share of $327.2M (spending exceeded operating cash flow)
Operating cash flow$238.2M
Capital expenditure($327.2M)
Free cash flow($89.0M)
Share buybacks—
Dividends paid—
Acquisitions (net)—
Net debt issued / (repaid)—
Stock-based compensation (non-cash)—

"—" means a year didn't report that line, so no total is shown rather than an estimate.

SEC filings

  • 10-K · period 2025-12-312026-02-24EDGAR

Ask anything about AbCellera Biologics Inc.'s filings

"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.

Start researching free

More companies

TEM TEMBloom Energy Corporation BERingCentral, Inc. RNGGH GHMDT MDTChipotle Mexican Grill, Inc. CMGALM ALMNetflix, Inc. NFLXCoreWeave, Inc. Class A Common Stock CRWVTM TMAlphabet GOOGWalmart Inc. WMTCredo Technologies CRDOMaxLinear, Inc. MXLMSTR MSTRNBIS NBISBHP Group BHPSE SELLY LLYPalo Alto Networks, Inc. PANWSalesforce, Inc. CRMSpace Exploration Technologies Corp. SPCXMeta Platforms, Inc. METANVIDIA Corporation NVDA